Sutro Biopharma (STRO) EBT Margin (2017 - 2025)
Sutro Biopharma's (STRO) quarterly EBT Margin came in at 709.76% in Q4 2025, down 175649.0% year-on-year from N/an in Q4 2024, and down 21.0% quarter-over-quarter from 586.58% in Q3 2025.
Sutro Biopharma (STRO) EBT Margin (2017 - 2025) Analysis & Trends
Sutro Biopharma has disclosed EBT Margin across 9 years of filings, most recently posting 709.76% for Q4 2025.
- EBT Margin for Q4 2025 came in at 709.76%, down 175649.0% year-over-year; the trailing twelve-month figure through Dec 2025 was 210.58% (changed N/A YoY), and the FY2025 annual result was 186.55%, changed N/A from the prior year.
- EBT Margin came in at 709.76% for Q4 2025 at Sutro Biopharma, down from 586.58% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 1046.73% in Q4 2024 to a low of 1146.05% in Q1 2025.
- The 5-year median for EBT Margin is 360.34% (2021), against an average of 290.25%.
- Across the five-year window, EBT Margin jumped 100551 bps in 2024 and plunged 175649 bps in 2025, its largest moves.
- Sutro Biopharma's EBT Margin stood at 357.85% in 2021, then retreated by 12 bps to 400.76% in 2022, then surged by 110 bps to 41.22% in 2023, then jumped by 2440 bps to 1046.73% in 2024, then sank by 168 bps to 709.76% in 2025.
- The last three EBT Margin figures came in at 709.76% (Q4 2025), 586.58% (Q3 2025), and 18.07% (Q2 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 6.40% |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 41.95% |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Sutro Biopharma | 252.04 Mn | 252.04 Mn | - | -709.76% |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -709.76% |
| Sep 30, 2025 | -586.58% |
| Jun 30, 2025 | -18.07% |
| Mar 31, 2025 | -1,146.05% |
| Dec 31, 2024 | 1,046.73% |
| Sep 30, 2024 | -572.62% |
| Jun 30, 2024 | -269.72% |
| Mar 31, 2024 | -447.52% |
| Dec 31, 2023 | 41.22% |
| Sep 30, 2023 | -280.34% |
| Jun 30, 2023 | -368.55% |
| Mar 31, 2023 | -391.79% |
| Dec 31, 2022 | -400.76% |
| Sep 30, 2022 | -77.50% |
| Jun 30, 2022 | -83.68% |
| Mar 31, 2022 | -663.22% |
| Dec 31, 2021 | -357.85% |
| Sep 30, 2021 | -362.83% |
| Jun 30, 2021 | -21.93% |
| Mar 31, 2021 | -134.17% |